Novartis AG
Process for concentration of antibodies and therapeutic products thereof

Last updated:

Abstract:

The present disclosure provides a process for concentrating proteins including an ultrafiltering, a diafiltering, and a second ultrafiltering sequence, at elevated temperatures, such as above about 30.degree. C. The disclosure also includes a process for preparing highly concentrated antibody compositions, and highly concentrated antibody products.

Status:
Grant
Type:

Utility

Filling date:

21 Apr 2014

Issue date:

6 Aug 2019